Front & Back Matter
Christian Dittrich(Leibniz Institute for Agricultural Engineering and Bioeconomy), Ken Kato, Maximilien Barret(Inserm), Salomon M. Stemmer(Tel Aviv University), Angelika Reiner‐Concin(Donauspital), Nobuaki Matsubara(National Cancer Center Hospital East), Ann‐Lii Cheng(National Taiwan University), M. Klimpfinger(Kaiser-Franz-Josef-Spital), Touraj Mansourbakht, Samy Louafi, Akito Sakai(The University of Tokyo), Julien Taı̈eb(Hôpital Européen Georges-Pompidou), David Sarid, I. Stephansky, Julia Greenberg, Sharon Pelles-Avraham, Ying‐Chun Shen(Johns Hopkins University), Cécile Dalban(Centre Léon Bérard), Tamar Safra, Thomas Aparicio(Université Paris Cité), Moshe Inbar(Assuta Medical Center), Eishiro Mizukoshi(Kanazawa Medical University), Wilfried Büchler(Kaiser-Franz-Josef-Spital), David Geffen(Ben-Gurion University of the Negev), Takeshi Terashima(Kobe University), Wolfgang Hulla(Fachhochschule Wiener Neustadt), Robert Königsberg(Kaiser-Franz-Josef-Spital), Jean‐Marc Sabaté, Akihito Tsuji(Kagawa University Hospital), Franck Bonnetain(Azienda Ospedaliera Universitaria Pisana), Kuniaki Arai(Kanazawa University), Teruyuki Ueda, Hajime Sunagozaka(Kouseiren Takaoka Hospital), Tanja Steininger(Kaiser-Franz-Josef-Spital), Hirofumi Mukai(National Cancer Center Hospital East), Yasunari Nakamoto(University of Fukui), Rinat Bernstein‐Molho(Tel Aviv University), Yasuhiro Shimada(Tokyo Metropolitan Komagome Hospital), Taro Yamashita(Kumamoto University), Shuichi Kaneko, Andrew X. Zhu, Junichi Matsubara(Kumamoto University Hospital), Kuniaki Itoh(National Cancer Center Hospital East), Christophe Locher(Centre Hospitalier Sud Francilien), David Malka(Inserm), Masao Honda, Alain Attar(Hôpital Saint Lazare), Tatsuya Yamashita, Robert Terkola, Shunji Nagai
Cited by 0
Related Papers
Pembrolizumab in patients with advanced hepatocellular carcinoma previously treated with sorafenib (KEYNOTE-224): a non-randomised, open-label phase 2 trial
|The Lancet Oncology|2018|2.5k
Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2016 for the treatment of colorectal cancer
|International Journal of Clinical Oncology|2017|2.5k
Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2019 for the treatment of colorectal cancer
|International Journal of Clinical Oncology|2019|2k
Pembrolizumab As Second-Line Therapy in Patients With Advanced Hepatocellular Carcinoma in KEYNOTE-240: A Randomized, Double-Blind, Phase III Trial
|Journal of Clinical Oncology|2019|1.8k
Preoperative Radiotherapy With or Without Concurrent Fluorouracil and Leucovorin in T3-4 Rectal Cancers: Results of FFCD 9203
|Journal of Clinical Oncology|2006|1.7k